DuPont de Nemours (DD)
(Delayed Data from NYSE)
$84.25 USD
+0.83 (0.99%)
Updated Aug 30, 2024 04:01 PM ET
After-Market: $84.22 -0.03 (-0.04%) 7:22 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
DuPont de Nemours (DD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$95.83 | $105.00 | $84.00 | 14.88% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for DuPont de Nemours comes to $95.83. The forecasts range from a low of $84.00 to a high of $105.00. The average price target represents an increase of 14.88% from the last closing price of $83.42.
Analyst Price Targets (12)
Broker Rating
DuPont de Nemours currently has an average brokerage recommendation (ABR) of 1.93 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.93 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 53.33% and 6.67% of all recommendations. A month ago, Strong Buy made up 53.33%, while Buy represented 6.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/DD.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.93 | 1.93 | 1.93 | 1.93 | 1.93 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/5/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/1/2024 | Not Identified | Not Identified | Hold | Hold |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
5/29/2024 | UBS | Joshua Spector | Strong Buy | Strong Buy |
5/28/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/24/2024 | Wells Fargo Securities | Michael J Sison | Hold | Strong Buy |
5/24/2024 | BMO Capital Markets | John P Mcnulty | Hold | Strong Buy |
5/17/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/2/2024 | Mizuho SecuritiesUSA | John Roberts | Strong Buy | Strong Buy |
5/2/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Hold | Hold |
3/1/2024 | Not Identified | Not Identified | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.93 |
ABR (Last week) | 1.93 |
# of Recs in ABR | 15 |
Average Target Price | $95.83 |
LT Growth Rate | 10.10% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 224 of 253 |
Current Quarter EPS Est: | 1.02 |